Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
10 March 2025Do policies that allow access to unregistered antimicrobials address the unmet need? Australia as a case study of a high-income country with universal healthcare
The study aimed to determine the average time for new antibacterials to gain registration in Australia and quantify the use of unregistered antimicrobials in Australian clinical practice between 2018 and 2023. Between 2018 and 2023, 36-131 applications were made to access unapproved antimicrobials, with 26.6% of cases involving critically ill patients. The most frequently accessed […]
Read more... -
10 March 2025Using a Difficult-to-treat Resistance Index to Gauge Imbalance between Countries’ Antibiotic Resistance Prevalence and Access to Antibiotics: A Scoping Review and Concept Proposal
The difficult-to-treat resistance (DTR) definition provides a global framework for assessing the impact of antimicrobial resistance on patient outcomes. A scoping review was conducted to understand the international adoption, scalability, and prognostic utility of DTR and to incorporate antibiotic access into the DTR framework. The study found that DTR was used in 57 studies across […]
Read more... -
10 March 2025Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches
Bacteriophage therapy is a promising solution for multidrug-resistant infections, with successful case series. However, hurdles remain in widespread adoption. This review provides an overview of current phage therapy technologies and therapeutic approaches, identifying knowledge gaps in cocktail design, formulation, pharmacology, and clinical trial design. A structured drug development pipeline and sustained government support are crucial […]
Read more...
More news related to Healthy patients
